Latest filing published 02 Oct 2013 for Evoke Pharma Inc.
Insider track record
No signal scores available.
Scott L. Glenn: trading record in brief
Scott L. Glenn discloses dealings in 2 companies, chiefly Somaxon Pharmaceuticals, Inc. and Evoke Pharma Inc. We count 4 filings; the first trade dates from 15 May 2007 and the latest from 30 September 2013.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 2 October 2013 with a transaction in Evoke Pharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Scott L. Glenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,605 sharesCommon StockSEC:0001209191-13-046787:0
- 10,000 shares@ US$2.40Common StockSEC:0001209191-07-031131:0
- 5,833 shares@ US$3.00Common StockSEC:0001209191-07-031131:1
- 3,333 shares@ US$3.00Common StockSEC:0001209191-07-031131:2
4 of 4 declarations